The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

FDMT FINANCIAL STATEMENTS

4D Molecular Therapeutics Inc — balance sheet, income statement and cash flow trends

FDMT4D Molecular Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M-100 M0100 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue92 M $Gross Profit38.6 M $ · 42%Operating Income-197.1 M $ · -214%Pre-tax Income-179.2 M $ · -195%Net Income to Owners-179.2 M $ · -195%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue92 M $+278,712.1%
Gross Profit38.6 M $—
Operating Income-197.1 M $—
EBITDA-184.9 M $—
Net Income to Owners-179.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets492.6 M
  • Equity407.7 M $83%
  • Current Liabilities47.7 M $10%
  • Long-term Liabilities37.3 M $8%

Key Figures

YoY change
Total Assets492.6 M $+4.0%
Total Liabilities85 M $+61.1%
Total Equity407.7 M $-3.1%
Cash & ST Investments361.3 M $+23.2%
Total Debt39.2 M $+69.9%
Net Debt-31.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-150 M-100 M-50 M0-156.1 M $Operating-16.6 M $Investing165.9 M $Financing-6.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-156.1 M $—
Capital Expenditures777 K $-77.3%
Free Cash Flow-156.7 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on FDMT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.